Journey Strategic Wealth LLC raised its stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 22.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,803 shares of the company’s stock after purchasing an additional 889 shares during the quarter. Journey Strategic Wealth LLC’s holdings in DocuSign were worth $432,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. DAVENPORT & Co LLC lifted its stake in DocuSign by 11.9% during the 4th quarter. DAVENPORT & Co LLC now owns 12,826 shares of the company’s stock valued at $1,154,000 after acquiring an additional 1,363 shares during the period. Tokio Marine Asset Management Co. Ltd. increased its stake in DocuSign by 2.7% during the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,267 shares of the company’s stock worth $654,000 after buying an additional 190 shares in the last quarter. Caprock Group LLC raised its stake in DocuSign by 16.4% in the 4th quarter. Caprock Group LLC now owns 5,989 shares of the company’s stock valued at $539,000 after purchasing an additional 844 shares during the last quarter. Mine & Arao Wealth Creation & Management LLC. acquired a new stake in shares of DocuSign in the fourth quarter valued at about $221,000. Finally, Oak Harvest Investment Services lifted its stake in DocuSign by 70.6% in the 4th quarter. Oak Harvest Investment Services now owns 18,770 shares of the company’s stock worth $1,688,000 after purchasing an additional 7,770 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have recently commented on DOCU. Wells Fargo & Company lifted their price target on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research note on Friday, December 6th. JMP Securities reissued a “market outperform” rating and issued a $124.00 price objective on shares of DocuSign in a research note on Tuesday, January 7th. Robert W. Baird lifted their target price on DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Finally, HSBC reiterated a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $92.45.
DocuSign Price Performance
NASDAQ:DOCU opened at $96.73 on Monday. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The firm has a market cap of $19.54 billion, a price-to-earnings ratio of 19.94, a price-to-earnings-growth ratio of 8.63 and a beta of 0.88. The firm’s fifty day moving average price is $91.32 and its 200 day moving average price is $72.96.
Insider Transactions at DocuSign
In other DocuSign news, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $94.60, for a total transaction of $50,516.40. Following the completion of the transaction, the director now owns 7,736 shares in the company, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Allan C. Thygesen sold 7,763 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the sale, the chief executive officer now directly owns 100,062 shares in the company, valued at approximately $8,058,993.48. The trade was a 7.20 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 685,773 shares of company stock worth $66,032,726 over the last ninety days. 1.66% of the stock is currently owned by company insiders.
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- Differences Between Momentum Investing and Long Term Investing
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- 3 Grocery Stocks That Are Proving They Are Still Essential
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.